Data monitoring in complex clinical trials: Which treatment is better?

DOI10.1016/0378-3758(94)90199-6zbMATH Open0825.62899OpenAlexW2003324233MaRDI QIDQ1338366FDOQ1338366

Janet Wittes, K. K. Gordon Lan

Publication date: 28 November 1995

Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/0378-3758(94)90199-6

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials
• Discrete Sequential Boundaries for Clinical Trials
• Stochastically curtailed tests in long–term clinical trials
• Predictive Probability Early Termination Plans For Phase II Clinical Trials

This page was built for publication: Data monitoring in complex clinical trials: Which treatment is better?

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1338366)